-
Investment type
-
Equity / Common Shares
-
Latest Disclosed Shares Owned
-
508,710 shares
-
Security Ownership %
-
20%
Hanmi Pharmaceutical Co., Ltd. ownership in Aptose Biosciences Inc. Common Shares
20 Mar 2025 - Hanmi Pharmaceutical Co., Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 508,710 shares of Aptose Biosciences Inc. Common Shares.
This represents 20% ownership of the company.
This is the first filing by Hanmi Pharmaceutical Co., Ltd. disclosing ownership of Aptose Biosciences Inc. Common Shares.